NEVIN CORCORAN: Open Payments
NPI 1285110213 · SPRINGFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$804 in 25 payments from 9 companies in 2025. Trend: 2023 $623 · 2024 $1,012 · 2025 $804
Food & beverage: $794Education: $10
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 6 | $287 |
| Janssen Biotech, Inc. | 7 | $186 |
| Regeneron Healthcare Solutions, Inc. | 1 | $94 |
| ABBVIE INC. | 3 | $71 |
| Ardelyx, Inc. | 3 | $62 |
| GENZYME CORPORATION | 1 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
| Janssen Pharmaceuticals, Inc | 1 | $10 |
Products named: REZDIFFRA, TREMFYA, DUPIXENT, SKYRIZI, IBSRELA, ENTYVIO, ZENPEP.
Industry payments across IL — which companies pay providers there.
